Steroid intramuscular injection side effects

Common (1% to 10%): Sinusitis, nasopharyngitis, upper respiratory tract infection , bronchitis
Uncommon (% to 1%): Cough, dyspnea, snoring, dysphonia
Rare (less than %): Pulmonary microembolism (POME) (cough, dyspnea, malaise, hyperhidrosis, chest pain, dizziness, paresthesia, or syncope) caused by oily solutions
Frequency not reported: Sleep apnea
Postmarketing reports: Chest pain, asthma , chronic obstructive pulmonary disease , hyperventilation, obstructive airway disorder, pharyngeal edema, pharyngolaryngeal pain, pulmonary embolism , respiratory distress, rhinitis , sleep apnea syndrome [ Ref ]

After the Kefauver Harris Amendment was passed in 1962, the . FDA began the DESI review process to ensure the safety and efficacy of drugs approved under the more lenient pre-1962 standards, including Dianabol. [26] In 1965, the FDA pressured CIBA to further document its legitimate medical uses, and re-approved the drug for treating post-menopausal osteoporosis and pituitary-deficient dwarfism . [27] After CIBA's patent exclusivity period lapsed, other manufacturers began to market generic metandienone in the .

Steroid intramuscular injection side effects

steroid intramuscular injection side effects

Media:

steroid intramuscular injection side effectssteroid intramuscular injection side effectssteroid intramuscular injection side effectssteroid intramuscular injection side effectssteroid intramuscular injection side effects

http://buy-steroids.org